ArticleCancer medicine2019

Persistent janus kinase-signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial.

David E Spaner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.